FACCHETTI, RITA LUCIA
 Distribuzione geografica
Continente #
NA - Nord America 15.478
AS - Asia 8.607
EU - Europa 7.381
SA - Sud America 1.390
AF - Africa 142
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 12
Totale 33.027
Nazione #
US - Stati Uniti d'America 15.098
SG - Singapore 3.591
CN - Cina 2.089
RU - Federazione Russa 1.435
DE - Germania 1.432
HK - Hong Kong 1.395
BR - Brasile 1.162
IT - Italia 1.001
SE - Svezia 978
IE - Irlanda 802
VN - Vietnam 677
UA - Ucraina 513
GB - Regno Unito 435
CA - Canada 277
FI - Finlandia 190
IN - India 187
FR - Francia 157
KR - Corea 145
AR - Argentina 94
BD - Bangladesh 92
TR - Turchia 65
ID - Indonesia 64
DK - Danimarca 61
MX - Messico 61
PL - Polonia 58
NL - Olanda 57
ZA - Sudafrica 57
AT - Austria 56
JP - Giappone 52
IQ - Iraq 48
BE - Belgio 45
EC - Ecuador 44
ES - Italia 36
CZ - Repubblica Ceca 30
PH - Filippine 25
UZ - Uzbekistan 24
PK - Pakistan 21
VE - Venezuela 21
CO - Colombia 17
IR - Iran 17
AE - Emirati Arabi Uniti 16
SA - Arabia Saudita 16
EG - Egitto 15
PY - Paraguay 15
LT - Lituania 13
MA - Marocco 12
PE - Perù 12
CL - Cile 11
EU - Europa 11
KE - Kenya 11
RO - Romania 11
TN - Tunisia 11
AU - Australia 10
MY - Malesia 10
TW - Taiwan 9
UY - Uruguay 9
CH - Svizzera 8
JM - Giamaica 8
ET - Etiopia 7
KZ - Kazakistan 7
PA - Panama 7
PT - Portogallo 7
TT - Trinidad e Tobago 7
AL - Albania 6
AZ - Azerbaigian 6
BG - Bulgaria 6
CM - Camerun 6
LK - Sri Lanka 6
SK - Slovacchia (Repubblica Slovacca) 6
BB - Barbados 5
CR - Costa Rica 5
GR - Grecia 5
IL - Israele 5
JO - Giordania 5
MK - Macedonia 5
HN - Honduras 4
HR - Croazia 4
KH - Cambogia 4
LV - Lettonia 4
NG - Nigeria 4
NP - Nepal 4
RS - Serbia 4
SN - Senegal 4
TH - Thailandia 4
XK - ???statistics.table.value.countryCode.XK??? 4
BJ - Benin 3
BO - Bolivia 3
BY - Bielorussia 3
EE - Estonia 3
GE - Georgia 3
HU - Ungheria 3
KW - Kuwait 3
LB - Libano 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
GT - Guatemala 2
GY - Guiana 2
Totale 32.996
Città #
Ann Arbor 2.133
Singapore 1.920
Ashburn 1.419
Hong Kong 1.384
Woodbridge 1.163
Fairfield 945
Houston 930
Dublin 768
Chandler 756
Frankfurt am Main 625
Wilmington 594
Jacksonville 553
New York 516
Dearborn 469
Seattle 434
Beijing 376
Cambridge 363
Dallas 358
Milan 343
Hefei 328
Santa Clara 315
Princeton 284
Los Angeles 245
Ho Chi Minh City 206
Nanjing 157
Moscow 149
Seoul 139
Shanghai 134
Lawrence 129
Munich 129
Altamura 127
Hanoi 118
Chicago 117
São Paulo 110
Buffalo 107
Lachine 92
San Diego 92
The Dalles 83
Boardman 63
Nanchang 59
Dong Ket 58
Toronto 57
Guangzhou 53
Helsinki 53
Rio de Janeiro 52
Andover 49
London 48
Ottawa 48
Falls Church 47
Warsaw 46
Brooklyn 45
Council Bluffs 45
Hebei 43
Shenyang 42
Atlanta 40
Fremont 40
Tianjin 40
Tokyo 40
Nürnberg 39
Lissone 38
Brussels 37
Montreal 37
Jakarta 35
Denver 34
Salt Lake City 34
Turku 34
Changsha 33
Vienna 33
Orem 32
Phoenix 32
Jinan 29
Mumbai 29
Norwalk 29
Nuremberg 29
Stockholm 28
Columbus 27
Pune 26
Zhengzhou 26
Belo Horizonte 25
Brno 25
Chennai 24
Haiphong 24
Da Nang 23
Jiaxing 23
Johannesburg 23
Kunming 23
Monza 21
Poplar 21
Rome 21
Manchester 20
Mexico City 20
Dhaka 19
Hangzhou 19
Ningbo 19
Porto Alegre 19
Quito 19
Tashkent 19
Boston 18
San Francisco 18
Quận Bình Thạnh 17
Totale 21.179
Nome #
Relationship between arterial distensibility and coronary atherosclerosis in angina patients 405
The impact of systolic and diastolic blood pressure variability on mortality is age dependent: Data from the Dublin Outcome Study 385
Self-reported prevalence of sleep disorders among medical and nursing students 361
Persistence of arterial functional abnormalities after successful coronary revascularization 352
Re-evaluation of clinical and histological criteria for diagnosis of dysmetabolic iron overload syndrome 329
Early alterations in left ventricular diastolic function in normotensive diabetic patients 323
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study 317
Determinants of carotid-femoral pulse wave velocity progression in hypertensive patients over a 3.7 years follow-up 303
Differing associations for sport versus occupational physical activity and cardiovascular risk 300
Gender-related differences in serum uric acid in treated hypertensive patients fromcentral and east European countries: Findings from the blood pressure control rate and cardiovascular risk profile study 293
Risk behaviors among Italian healthcare students: a cross-sectional study for health promotion of future healthcare workers 283
Biological consequences of stress: Conflicting findings on the association between job strain and blood pressure 281
Could two-dimensional radial strain be considered as a novel tool to identify pre-clinical hypertrophic cardiomyopathy mutation carriers? 281
Sympathetic and baroreflex alterations in congestive heart failure with preserved, midrange and reduced ejection fraction. 279
8c.04: Possible role of arterial function in cancer treatment targeting vascular endothelial growth factor receptor oncologic response 270
Left ventricular hypertrophy increases cardiovascular risk independently of in-office and out-of-office blood pressure values 269
Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population 266
Alterations in sympathetic nerve traffic in genetic haemochromatosis before and after iron depletion therapy: A microneurographic study 264
The Pamela study: main findings and perspectives 263
Cardiovascular risk factor profile in an italian cohort of patients with rheumatoid arthritis: results of a three years follow-up 263
Prognostic relevance of electrocardiographic Tpeak-Tend interval in the general and in the hypertensive population: Data from the Pressioni Arteriose Monitorate e Loro Associazioni study 262
Multiparametric carotid and cardiac ultrasound compared with clinical risk scores for the prediction of angiographic coronary artery disease: A multicenter prospective study 260
Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study 259
Habitual coffee consumption and risk of cardiovascular and all-cause mortality in the PAMELA hypertensive population 250
Effects of Cancer Therapy Targeting Vascular Endothelial Growth Factor Receptor on Central Blood Pressure and Cardiovascular System 248
Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis 247
Ultrasound carotid intima-media thickness, carotid plaque and cardiac calcium incrementally add to the Framingham Risk Score for the prediction of angiographic coronary artery disease : a multicenter prospective study 245
Evaluation of How Gene-Job Strain Interaction Affects Blood Pressure in the PAMELA Study 243
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities 238
Prevalence and clinical significance of a greater ambulatory versus office blood pressure ('reversed white coat' condition) in a general population 237
Accuracy evaluation of the 'Cardiette BP one' ambulatory blood pressure monitor 236
Adding Home and/or Ambulatory Blood Pressure to Office Blood Pressure for Cardiovascular Risk Prediction 234
Sympathetic nerve traffic and baroreflex function in optimal, normal, and high-normal blood pressure states 234
Comparison between non-invasive and invasive pulse wave velocity assessment in human beings 232
Relationship between vascular damage and left ventricular concentric geometry in patients undergoing coronary angiography: a multicenter prospective study 231
Multiple sampling improves norepinephrine reproducibility in essential hypertension: a comparison with the microneurographic technique 226
Relationships between residual blood pressure variability and cognitive function in the general population of the PAMELA study 226
Prognostic Significance of Left Atrial Enlargement in a General Population: Results of the PAMELA Study 225
High normal blood pressure and left ventricular hypertrophy echocardiographic findings from the PAMELA population 223
Relationships between diuretic-related hyperuricemia and cardiovascular events: data from the URic acid Right for heArt Health study 222
Reproducibility patterns of plasma norepinephrine and muscle sympathetic nerve traffic in human obesity 218
Impact of different definitions of the metabolic syndrome on the prevalence of organ damage, cardiometabolic risk and cardiovascular events 218
Differential incremental value of ultrasound carotid intima-media thickness, carotid plaque, and cardiac calcium to predict angiographic coronary artery disease across Framingham risk score strata in the APRES multicentre study 218
Long-term prognostic value of blood pressure variability in the general population: results of the Pressioni Arteriose Monitorate e Loro Associazioni Study 218
Impact of blood glucose variability on carotid artery intima media thickness and distensibility in type 1 diabetes mellitus 217
Relationship of office, home, and ambulatory blood pressure to blood glucose and lipid variables in the PAMELA population 215
New-onset left atrial enlargement in a general population 215
Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure 214
Normal values of left-ventricular mass: echocardiographic findings from the PAMELA study 214
Increased long-term risk of new-onset diabetes mellitus in white-coat and masked hypertension 212
Metabolic syndrome in human immunodeficiency virus-positive subjects: prevalence, phenotype, and related alterations in arterial structure and function 211
Blood pressure variability and organ damage in a general population: Results from the PAMELA study 210
Ultrasonographic backscatter of the carotid artery wall in patients with HIV infection: a pilot study 210
Impact of demographic, anthropometric, haemodynamic factors on left atrial size in the general population: data from the PAMELA study 208
Prognostic value of serum uric acid: new-onset in and out-of-office hypertension and long-term mortality 206
Limited reproducibility of MUCH and WUCH: Evidence from the ELSA study 206
Response to possible difference in the sympathetic activation on extreme dippers with or without exaggerated morining surge 204
Relationship among morning blood pressure surge, 24-hour blood pressure variability, and cardiovascular outcomes in a white population 204
Biological and social values of metabolic syndrome in predicting cardiovascular disease 203
Annexin A5 in treated hypertensive patients and its association with target organ damage 201
Differential value of left ventricular mass index and wall thickness in predicting cardiovascular prognosis: Data from the PAMELA population 198
Simultaneous validation of the SunTech 247 diagnostic station blood pressure measurement device according to the British hypertension society protocol, the international protocol and the association for the advancement of medical instrumentation standards 197
Is night-time hypertension worse than daytime hypertension? A study on cardiac damage in a general population: The PAMELA study 197
Should white-coat hypertension in diabetes be treated? Pro 196
Incident Left Ventricular Hypertrophy in Masked Hypertension 196
HIV and metabolic syndrome - A comparison with the general population 195
THE role of metabolic syndrome in blood pressure control and pulse wave velocity progression over a 3.5 years in treated hypertensive PATIENTS 195
Impact of body mass index and waist circumference on the cardiovascular risk and all-cause death in a general population: Data from the PAMELA study 194
Clinic, home, 24-hour blood pressure profiles and clinical correlates in resistant hypertension: data from the PAMELA Study 193
The PAMELA (Pressioni Arteriose Monitorate E Loro Associazioni) study: Main features and results 193
Uric Acid and New Onset Left Ventricular Hypertrophy: Findings From the PAMELA Population 193
Within-visit BP variability, cardiovascular risk factors, and BP control in central and eastern Europe: Findings from the BP-CARE study 190
Blood Pressure Responses to Renal Denervation Precede and Are Independent of the Sympathetic and Baroreflex Effects 188
Prognostic impact of late gadolinium enhancement in the risk stratification of heart transplant patients 187
High-normal blood pressure and abnormal left ventricular geometric patterns: A meta-analysis 187
One isoform of Arg/Abl2 tyrosine kinase is nuclear and the other seven cytosolic isoforms differently modulate cell morphology, motility and the cytoskeleton 187
The Pamela Study: Old and New Findings 186
Blood pressure (clinic, home, 24-h) profiles and clinical correlates in 186
Long-term prognistic value of white-coat hypertension: an insight from diagnostic use of both ambulatory and home blood pressure measurements 184
Impact of body mass index and waist circumference on the long-term risk of diabetes mellitus, hypertension, and cardiac organ damage 182
Predictive value of different indices of blood pressure variability on 182
Do Combined Electrocardiographic and Echocardiographic Markers of Left Ventricular Hypertrophy Improve Cardiovascular Risk Estimation? 181
Prognostic value of "partial" and "true" white coat hypertension: data from 16 year follow-up in the PAMELA population 180
Reinforcement of the adrenergic overdrive in the metabolic syndrome complicated by obstructive sleep apnea 179
Home and ambulatory blood pressure in resistant hypertension 178
Indexing cardiac parameters in echocardiographic practice: do estimates depend on how weight and height have been assessed? A study on left atrial dilatation 177
Long-term risk of sustained hypertension in white-coat or masked hypertension 175
4C.07:Relationships between cognitive dysfunction, clinic and ambulatory blood pressure and blood pressure variability: results from the PAMELA Study 175
Haemophilia management and treatment: An Italian survey on patients’, caregivers’ and clinicians’ point of view 174
Serum uric acid and resistance to antihypertensive treatment: data from the European Lacidipine Study on Atherosclerosis 173
Clinical correlates and subclinical cardiac organ damage in different extreme dipping patterns 172
Disturbi del sonno in una popolazione di studenti delle lauree sanitarie. Associazioni con lo stress, lavoro a turni e ripercussioni sulla performance accademica percepita 171
Prevalence and correlates of new-onset left ventricular geometric abnormalities in a general population: The PAMELA study 170
Adrenergic, metabolic, and reflex abnormalities in reverse and extreme dipper hypertensives 169
Aortic root diameter and risk of cardiovascular events in a general population: data from the PAMELA study 168
Delisting HCV-infected liver transplant candidates who improved after viral eradication: Outcome 2 years after delisting 168
Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study 168
Comparison of electrocardiographic versus echocardiographic detection of left ventricular mass changes over time and evaluation of new onset left ventricular hypertrophy 167
Nighttime Blood Pressure and New-Onset Left Ventricular Hypertrophy: Findings From the Pamela Population 163
Prevalence and clinical characteristics of patients with true resistant hypertension in central and Eastern Europe: data from the BP-CARE study 163
Totale 22.364
Categoria #
all - tutte 119.326
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.326


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.785 0 0 0 0 0 239 312 320 199 286 144 285
2021/20221.836 104 157 198 169 138 146 91 90 99 156 137 351
2022/20233.192 388 955 276 284 175 502 61 201 187 30 91 42
2023/20242.685 75 68 115 154 352 711 482 104 224 59 47 294
2024/20257.114 344 791 303 290 563 183 358 351 609 965 939 1.418
2025/20267.911 1.794 1.010 1.259 1.768 1.884 196 0 0 0 0 0 0
Totale 33.876